New radiotherapy technique aims to cut prostate cancer treatment side effects

NCT ID NCT07245745

Recruiting now Symptom relief Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares adaptive radiotherapy (ART) with conventional radiotherapy in 188 men with prostate cancer. ART adjusts the radiation beam daily to account for changes in organ position, potentially reducing digestive and urinary side effects. Patients will report their symptoms through questionnaires and a mobile app. The goal is to see if ART leads to fewer and shorter-lasting side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Radiotherapy (adaptive vs. conventional)
What this could lead to: If successful, adaptive radiotherapy could become a standard approach to reduce digestive and urinary side effects during prostate cancer treatment.
What could go wrong: This is a non-randomized, observational study with only 188 participants, so results may not apply broadly. The adaptive technique may not significantly reduce side effects compared to conventional methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Cliniques universitaires Saint-Luc
RECRUITING

Brussels, 1200, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.